You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Amphista partners with Domainex to advance drug portfolio

Amphista – a company involved in the development of next generation targeted protein degradation (TPD) therapeutics – has linked up with Domainex in an integrated drug discovery partnership.